SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-05-010639
Filing Date
2005-12-06
Accepted
2005-12-06 17:03:06
Documents
2
Period of Report
2005-12-06
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. 8K a5034618.txt 8-K 3687
2 EXHIBIT 99.1 a5034618ex991.txt EX-99.1 9209
  Complete submission text file 0001157523-05-010639.txt   14437
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 051247634
SIC: 2836 Biological Products, (No Diagnostic Substances)